Format

Send to

Choose Destination
See comment in PubMed Commons below
BMJ Case Rep. 2013 Jun 19;2013. pii: bcr2013010090. doi: 10.1136/bcr-2013-010090.

Dabigatran, electrical cardioversion and measuring the aPTT. A safety measure or an unnecessary assessment?

Author information

1
Department of Cardiology, Ipswich Hospital, Suffolk, Ipswich, UK. avi.rahmat@yahoo.co.uk

Abstract

We present two case reports of patients treated with dabigatran for stroke prevention. Both have non-valvular atrial fibrillation and both were scheduled for direct current electrical cardioversion (DCCV). Both had their activated partial thromboplastin time (aPTT) measured prior to their DCCV to assess the anticoagulant activity of dabigatran. The decision to measure the aPTT resulted in differing levels to otherwise straightforward cases.

PMID:
23784770
PMCID:
PMC3702943
DOI:
10.1136/bcr-2013-010090
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center